Cue Biopharma Inc reports results for the quarter ended in March - Earnings Summary

Cue Biopharma

10/05/2023 01:18

* Cue Biopharma Inc  CUE.OQ  reported a quarterly adjusted
loss
of 29 cents​​ per share for the quarter ended in March. The mean
expectation of four analysts for the quarter was for a loss
of 29 cents per share.
    * Revenue fell 81.3% to $187.00 thousand from a year ago;
analysts
expected $1.95 million. 
    * Cue Biopharma Inc's reported EPS for the quarter was a
loss
of 29 cents​.
    * The mean earnings estimate of analysts had fallen by
about 8.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Cue Biopharma Inc shares had risen by 37.5% this
quarter and
gained 72.3% so far this year.
    * The company reported a quarterly loss of $13.11 million.
    * Wall Street's median 12-month price target for Cue
Biopharma Inc
is $9.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
10 at 12:18 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.29          -0.29          Met
 Dec. 31 2022      -0.31          -0.38          Missed
 Sep. 30 2022      -0.38          -0.31          Beat
 Jun. 30 2022      -0.42          -0.37          Beat